1. Alberts D.S., Salmon S.E., Chen H. S. G., Surwit E. A., Soehnlen B., Young L., Moon T. E. In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet(2): 340–342, 1980.
2. Carter S. K. Cancer chemotherapy: new developments and changing concepts. Drugs(20): 375–397, 1980.
3. Fisher R. I., Chabner B. A., Myers C. E. Phase II study of high dose methotrexate in patients with advanced malignant melanoma. Cancer Treat Rep(63): 147–148, 1979.
4. Lazarus H. M., Herzig R. H., Graham-Pole J., Wolff S. N., Phillips G. L., Strandjord S., Hurd D., Forman W., Gordon E. M., Coccia P., Gross S., Herzig G. P. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. Jnl CIin Oncol(1): 359–367, 1983.
5. McElwain T. J., Powles R. L. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet (2): 822–824, 1983.